Fifth Third Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
22,010
+10,152
+86% +$888K 0.06% 205
2026
Q1
$1.01M Buy
11,858
+1,133
+11% +$101K 0.03% 268
2025
Q4
$847K Sell
10,725
-1,423
-12% -$112K 0.03% 285
2025
Q3
$971K Buy
12,148
+342
+3% +$29.2K 0.04% 247
2025
Q2
$1.07M Buy
11,806
+231
+2% +$21.1K 0.05% 226
2025
Q1
$1.08M Buy
11,575
+808
+8% +$72.3K 0.06% 209
2024
Q4
$979K Buy
10,767
+1,272
+13% +$121K 0.05% 204
2024
Q3
$986K Buy
9,495
+34
+0.4% +$3.46K 0.06% 192
2024
Q2
$918K Buy
9,461
+6,740
+248% +$622K 0.07% 173
2024
Q1
$245K Buy
+2,721
New +$231K 0.04% 213

Other funds holding CL

Fifth Third Wealth Advisors's CL Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Colgate-Palmolive (CL) stake by 86% in Q2 2026, buying an estimated $888K and bringing the position to 22,010 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #205.

Fifth Third Wealth Advisors first reported a position in CL in Q1 2024 and has held it in 10 quarters since. 385 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fifth Third Wealth Advisors held 22,010 shares of Colgate-Palmolive worth $2.02M as of Q2 2026.
  • Fifth Third Wealth Advisors bought 10,152 Colgate-Palmolive shares in Q2 2026, an estimated $888K.
  • Colgate-Palmolive made up 0.06% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #205 holding.
  • Fifth Third Wealth Advisors first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • 385 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.